{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T02:24:45Z","timestamp":1793413485009,"version":"4.5.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.vaccine.2021.02.018","type":"journal-article","created":{"date-parts":[[2021,2,25]],"date-time":"2021-02-25T19:10:56Z","timestamp":1614280256000},"page":"1572-1582","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Systematic review and meta-analysis of the effect of pertussis vaccine in pregnancy on the risk of chorioamnionitis, non-pertussis infectious diseases and other adverse pregnancy outcomes"],"prefix":"10.1016","volume":"40","author":[{"given":"A.R.","family":"Andersen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.K.","family":"Kolmos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.L.","family":"Flanagan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.S.","family":"Benn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2021.02.018_b0005","unstructured":"WHO. Pertussis 2015 [updated May 21, 2015. Available from: https:\/\/www.who.int\/biologicals\/vaccines\/pertussis\/en\/."},{"key":"10.1016\/j.vaccine.2021.02.018_b0010","doi-asserted-by":"crossref","unstructured":"Vygen-Bonnet S, Hellenbrand W, Garbe E, von Kries R, Bogdan C, Heininger U, et al. Safety and effectiveness of acellular pertussis vaccination during pregnancy: A systematic review. BMC Infectious Diseases. 2020;20(1):136.","DOI":"10.1186\/s12879-020-4824-3"},{"issue":"9953","key":"10.1016\/j.vaccine.2021.02.018_b0015","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/S0140-6736(14)60686-3","article-title":"Effectiveness of maternal pertussis vaccination in England: an observational study","volume":"384","author":"Amirthalingam","year":"2014","journal-title":"The Lancet."},{"key":"10.1016\/j.vaccine.2021.02.018_b0020","unstructured":"WHO. Pertussis Vaccines: WHO position paper - August 2015 2015 [Available from: https:\/\/www.who.int\/wer\/2015\/wer9035.pdf?ua=1."},{"issue":"8","key":"10.1016\/j.vaccine.2021.02.018_b0025","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/s41577-020-0338-x","article-title":"The non-specific and sex-differential effects of vaccines","volume":"20","author":"Aaby","year":"2020","journal-title":"Nat Rev Immunol"},{"issue":"9","key":"10.1016\/j.vaccine.2021.02.018_b0030","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.it.2013.04.004","article-title":"A small jab \u2013 a big effect: nonspecific immunomodulation by vaccines","volume":"34","author":"Benn","year":"2013","journal-title":"Trends Immunol"},{"issue":"10","key":"10.1016\/j.vaccine.2021.02.018_b0035","doi-asserted-by":"crossref","first-page":"e274","DOI":"10.1016\/S1473-3099(19)30742-X","article-title":"Vaccinology: time to change the paradigm?","volume":"20","author":"Benn","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2021.02.018_b0040","article-title":"Association of BCG, DTP, and measles containing vaccines with childhood mortality: systematic review","volume":"355","author":"Higgins","year":"2016","journal-title":"BMJ"},{"issue":"10","key":"10.1016\/j.vaccine.2021.02.018_b0045","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1093\/trstmh\/trw073","article-title":"Is diphtheria-tetanus-pertussis (DTP) associated with increased female mortality? A meta-analysis testing the hypotheses of sex-differential non-specific effects of DTP vaccine","volume":"110","author":"Aaby","year":"2016","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"4","key":"10.1016\/j.vaccine.2021.02.018_b0050","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.smim.2016.05.005","article-title":"Unravelling the nature of non-specific effects of vaccines\u2014a challenge for innate immunologists","volume":"28","author":"Jensen","year":"2016","journal-title":"Semin Immunol"},{"issue":"9","key":"10.1016\/j.vaccine.2021.02.018_b0055","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1093\/cid\/ciw492","article-title":"Sex-differential non-vaccine-specific immunological effects of diphtheria-tetanus-pertussis and measles vaccination","volume":"63","author":"Noho-Konteh","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"29","key":"10.1016\/j.vaccine.2021.02.018_b0060","doi-asserted-by":"crossref","first-page":"3655","DOI":"10.1016\/j.vaccine.2017.05.041","article-title":"Maternal Tdap vaccination and risk of infant morbidity","volume":"35","author":"DeSilva","year":"2017","journal-title":"Vaccine"},{"issue":"33","key":"10.1016\/j.vaccine.2021.02.018_b0065","doi-asserted-by":"crossref","first-page":"4072","DOI":"10.1016\/j.vaccine.2017.06.071","article-title":"Prenatal Tdap immunization and risk of maternal and newborn adverse events","volume":"35","author":"Layton","year":"2017","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2021.02.018_b0070","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.clp.2010.02.003","article-title":"Diagnosis and management of clinical chorioamnionitis","volume":"37","author":"Tita","year":"2010","journal-title":"Clin Perinatol"},{"key":"10.1016\/j.vaccine.2021.02.018_b0075","unstructured":"Andersen AR, Kolmos SK, Benn CS. Systematic review with meta-analysis on the effect of pertussis vaccine in pregnancy on the risk of chorioamnionitis, non-pertussis infectious diseases and other adverse pregnancy outcomes 2020 [Available from: https:\/\/www.crd.york.ac.uk\/prospero\/display_record.php?ID=CRD42020181142."},{"issue":"4","key":"10.1016\/j.vaccine.2021.02.018_b0080","doi-asserted-by":"crossref","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"151","author":"Moher","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.vaccine.2021.02.018_b0085","unstructured":"Covidence. Covidence - Better Systematic Review Management [Available from: https:\/\/www.covidence.org\/home."},{"key":"10.1016\/j.vaccine.2021.02.018_b0090","unstructured":"Review Manager (RevMan). 5.3 ed. Copenhagen: The Nordic Cochrane Center: The Cochrane Collaboration; 2014."},{"key":"10.1016\/j.vaccine.2021.02.018_b0095","unstructured":"Institute TOHR. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses [Available from: http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp."},{"key":"10.1016\/j.vaccine.2021.02.018_b0100","unstructured":"The Cochrane Collaboration. 16.9.2 Studies with zero-cell counts 2011 [Available from: https:\/\/handbook-5-1.cochrane.org\/chapter_16\/16_9_2_studies_with_zero_cell_counts.htm."},{"issue":"18","key":"10.1016\/j.vaccine.2021.02.018_b0105","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1001\/jama.2014.14825","article-title":"Evaluation of the association of maternal pertussis vaccination with obstetric events and birth outcomes","volume":"312","author":"Kharbanda","year":"2014","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.vaccine.2021.02.018_b0110","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.vaccine.2015.10.100","article-title":"Pertussis vaccination during pregnancy in Belgium: results of a prospective controlled cohort study","volume":"34","author":"Maertens","year":"2016","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2021.02.018_b0115","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1080\/21645515.2016.1157241","article-title":"Maternal and infant outcomes among women vaccinated against pertussis during pregnancy","volume":"12","author":"Berenson","year":"2016","journal-title":"Human Vacc. Immunotherapeutics"},{"key":"10.1016\/j.vaccine.2021.02.018_b0120","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.g4219","article-title":"Safety of pertussis vaccination in pregnant women in UK: observational study","volume":"349","author":"Donegan","year":"2014","journal-title":"BMJ"},{"issue":"34","key":"10.1016\/j.vaccine.2021.02.018_b0125","doi-asserted-by":"crossref","first-page":"5173","DOI":"10.1016\/j.vaccine.2018.07.011","article-title":"Pertussis Immunisation in Pregnancy Safety (PIPS) Study: a retrospective cohort study of safety outcomes in pregnant women vaccinated with Tdap vaccine","volume":"36","author":"Griffin","year":"2018","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2021.02.018_b0130","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1016\/j.vaccine.2020.01.009","article-title":"Safety of tetanus, diphtheria, and acellular pertussis vaccination among pregnant active duty U.S. military women","volume":"38","author":"Hall","year":"2020","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2021.02.018_b0135","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1093\/cid\/ciy244","article-title":"A randomized controlled trial of the safety and immunogenicity of tetanus, diphtheria, and acellular pertussis vaccine immunization during pregnancy and subsequent infant immune response","volume":"67","author":"Halperin","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2021.02.018_b0140","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.vaccine.2015.10.098","article-title":"Pertussis vaccination during pregnancy in Vietnam: results of a randomized controlled trial Pertussis vaccination during pregnancy","volume":"34","author":"Hoang","year":"2016","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2021.02.018_b0145","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.vaccine.2015.12.046","article-title":"Maternal Tdap vaccination: coverage and acute safety outcomes in the vaccine safety datalink, 2007\u20132013","volume":"34","author":"Kharbanda","year":"2016","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2021.02.018_b0150","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.vaccine.2020.11.052","article-title":"Safety of maternal pertussis vaccination on pregnancy and birth outcomes: a prospective cohort study","volume":"39","author":"Mohammed","year":"2021","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2021.02.018_b0155","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1097\/AOG.0000000000000862","article-title":"Pregnancy outcomes after antepartum tetanus, diphtheria, and acellular pertussis vaccination","volume":"125","author":"Morgan","year":"2015","journal-title":"Obstet Gynecol"},{"issue":"17","key":"10.1016\/j.vaccine.2021.02.018_b0160","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1001\/jama.2014.3633","article-title":"Safety and immunogenicity of tetanus diphtheria and acellular pertussis (Tdap) immunization during pregnancy in mothers and infants: a randomized clinical trial","volume":"311","author":"Munoz","year":"2014","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.vaccine.2021.02.018_b0165","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1016\/j.vaccine.2019.10.105","article-title":"Immunogenicity, transplacental transfer of pertussis antibodies and safety following pertussis immunization during pregnancy: evidence from a randomized, placebo-controlled trial","volume":"38","author":"Perrett","year":"2020","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2021.02.018_b0170","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1016\/j.vaccine.2019.10.104","article-title":"Impact of tetanus-diphtheria-acellular pertussis immunization during pregnancy on subsequent infant immunization seroresponses: follow-up from a large randomized placebo-controlled trial","volume":"38","author":"Perrett","year":"2020","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2021.02.018_b0175","article-title":"A retrospective cohort study of safety outcomes in new Zealand infants exposed to Tdap vaccine in utero","volume":"7","author":"Petousis-Harris","year":"2019","journal-title":"Vaccines (Basel)"},{"issue":"12","key":"10.1016\/j.vaccine.2021.02.018_b0180","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1080\/21645515.2019.1627161","article-title":"Safety of reduced antigen content diphtheria-tetanus-acellular pertussis vaccine when administered during pregnancy as part of the maternal immunization program in Brazil: a single center, observational, retrospective, cohort study","volume":"15","author":"Sancovski","year":"2019","journal-title":"Human Vaccines and Immunotherapeutics."},{"key":"10.1016\/j.vaccine.2021.02.018_b0185","doi-asserted-by":"crossref","unstructured":"Shakib JH, Korgenski K, Sheng X, Varner MW, Pavia AT, Byington CL. Tetanus, diphtheria, acellular pertussis vaccine during pregnancy: Pregnancy and infant health outcomes. J Pediatr 2013;163(5):1422-6.e1-4.","DOI":"10.1016\/j.jpeds.2013.06.021"},{"issue":"12","key":"10.1016\/j.vaccine.2021.02.018_b0190","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1016\/j.vaccine.2020.01.074","article-title":"Seroprevalence of Bordetella pertussis antibodies and anti-pertussis antibody response after a single dose of reduced-antigen combined diphtheria, tetanus, and acellular pertussis vaccine (Tdap) in pregnant Thai women","volume":"38","author":"Sompagdee","year":"2020","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2021.02.018_b0195","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1093\/cid\/ciz246","article-title":"Interacting, nonspecific, immunological effects of bacille calmette-gu\u00e9rin and tetanus-diphtheria-pertussis inactivated polio vaccinations: an explorative","volume":"70","author":"Blok","year":"2020","journal-title":"Randomized Trial. Clin Infect Dis."},{"key":"10.1016\/j.vaccine.2021.02.018_b0200","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jclinepi.2018.05.021","article-title":"Three risk of bias tools lead to opposite conclusions in observational research synthesis","volume":"101","author":"Losilla","year":"2018","journal-title":"J Clin Epidemiol"},{"issue":"11","key":"10.1016\/j.vaccine.2021.02.018_b0205","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1055\/s-0034-1371357","article-title":"Epidural use and clinical chorioamnionitis among women who delivered vaginally","volume":"31","author":"Abramovici","year":"2014","journal-title":"Am J Perinatol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21001663?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21001663?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:10:09Z","timestamp":1759403409000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X21001663"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":41,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S0264410X21001663"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.02.018","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systematic review and meta-analysis of the effect of pertussis vaccine in pregnancy on the risk of chorioamnionitis, non-pertussis infectious diseases and other adverse pregnancy outcomes","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.02.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}